Buy, Sell, Or Hold? IREDA, Dr. Lal Path Labs, SBI On Shrikant Chouhan's Radar — Check Target Price
The stock recommendations come with specific target price and stop loss levels.
Shrikant Chouhan, head of equity research at Kotak Securities, has shared his latest stock recommendations, suggesting investors consider buying shares of Indian Renewable Energy Development Agency Ltd., Dr. Lal Path Labs Ltd., and State Bank Of India. Here’s a detailed look at each recommendation.
Chouhan suggests buying Ireda at current market price with a stop loss at Rs 164 and target price of Rs 181. Indian Renewable Energy Development Agency is a public sector enterprise under the Ministry of New and Renewable Energy. Established in 1987, IREDA provides financial assistance for projects related to renewable energy and energy efficiency.
Another suggestion from Chouhan is Dr. Lal Path Labs at current market price, with a stop loss at Rs 2,880 and target price of Rs 3,050.
Dr. Lal Path Labs, founded in 1949, is a leading diagnostic and healthcare service provider in India. The company offers a wide range of tests on blood, urine, and other human body samples through its extensive network of laboratories and collection centers.
Chouhan's third suggestion is State Bank Of India at current market price with a stop loss at Rs 807 and target price of Rs 825.
State Bank of India is the largest bank in India, with a significant market share in assets and deposits. Headquartered in Mumbai, SBI offers a comprehensive range of banking and financial services to individuals, businesses, and institutions
ALSO READ
Market Experts' LIVE Stock Recommendations: Should You Buy, Sell Or Hold These Stocks Today?
Disclaimer: The views and opinions expressed by the investment advisers on NDTV Profit are of their own and not of NDTV Profit. NDTV Profit advises users to consult with their own financial or investment adviser before taking any investment decision.
